Crossmark

Outcomes of linezolid, glycopeptides, and other regimens in ampicillin-resistant, vancomycin-susceptible and vancomycin-resistant enterococcal bacteremia in a resource-limited setting: stewardship implications

Crossref DOI link: https://doi.org/10.1007/s00210-026-05701-2

Published Online: 2026-07-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Yameena Noman

Mala, Ali

Murtaza, Rubab

Batool, Irshad

Khan, Azizullah

Begum, Imtiaz

Muqtadir, Jamil https://orcid.org/0000-0001-9828-4109
Rasheed, Abdul

Bhatti, Sameeullah
License Information

Text and Data Mining valid from 2026-07-12

Version of Record valid from 2026-07-12
More Information

Article History

Received: 14 April 2026

Accepted: 5 July 2026

First Online: 12 July 2026

Declarations

:

: All study procedures were conducted in accordance with the Declaration of Helsinki and were approved by the Dr. Ziauddin University Ethical Review Committee on April 13, 2025. The committee also waived the requirement for written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below